BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21320485)

  • 1. PTEN ameliorates high glucose-induced lipid deposits through regulating SREBP-1/FASN/ACC pathway in renal proximal tubular cells.
    Hao J; Zhu L; Zhao S; Liu S; Liu Q; Duan H
    Exp Cell Res; 2011 Jul; 317(11):1629-39. PubMed ID: 21320485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged high-glucose exposure decreased SREBP-1/FASN/ACC in Schwann cells of diabetic mice via blocking PI3K/Akt pathway.
    Zhu L; Du W; Liu Y; Cheng M; Wang X; Zhang C; Lv X; Li F; Zhao S; Hao J
    J Cell Biochem; 2019 Apr; 120(4):5777-5789. PubMed ID: 30362584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN Regulates Renal Extracellular Matrix Deposit via Increased CTGF in Diabetes Mellitus.
    Zhu L; Zhao S; Liu S; Liu Q; Li F; Hao J
    J Cell Biochem; 2016 May; 117(5):1187-98. PubMed ID: 26447680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K/Akt pathway mediates high glucose-induced lipid accumulation in human renal proximal tubular cells via spliced XBP-1.
    Zhao S; Zhu L; Duan H; Liu S; Liu Q; Liu W; Hao J
    J Cell Biochem; 2012 Oct; 113(10):3288-98. PubMed ID: 22644804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-regulation of SREBP-1 and mTOR ameliorates lipid accumulation in kidney of diabetic mice.
    Wang H; Zhu L; Hao J; Duan H; Liu S; Zhao S; Liu Q; Liu W
    Exp Cell Res; 2015 Aug; 336(1):76-84. PubMed ID: 26112216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospho-GSK-3β is involved in the high-glucose-mediated lipid deposition in renal tubular cells in diabetes.
    Liu W; Hao J; Zhu L; Li F; Liu Q; Liu S; Zhao S; Li H; Duan H
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2066-75. PubMed ID: 23880101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospho-mTOR: a novel target in regulation of renal lipid metabolism abnormality of diabetes.
    Hao J; Zhu L; Li F; Liu Q; Zhao X; Liu S; Xing L; Feng X; Duan H
    Exp Cell Res; 2013 Aug; 319(14):2296-306. PubMed ID: 23827786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC cells through regulation of SREBP-1 and TGF-β1.
    Hao J; Liu S; Zhao S; Liu Q; Lv X; Chen H; Niu Y; Duan H
    Histochem Cell Biol; 2011 Feb; 135(2):173-81. PubMed ID: 21240525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
    Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
    Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Down-regulation of PTEN expression in kidney and its role in development of diabetic nephropathy in rats].
    Wang YY; Liu RX; Guo B; Xiao Y; Shi MJ; Pi MJ; Wen QY; Zhang GZ
    Sheng Li Xue Bao; 2011 Aug; 63(4):325-32. PubMed ID: 21861051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
    Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated microRNA-32 expression induced by high glucose inhibits cell cycle progression via PTEN upregulation and Akt inactivation in bone marrow-derived mesenchymal stem cells.
    Zhu G; Chai J; Ma L; Duan H; Zhang H
    Biochem Biophys Res Commun; 2013 Apr; 433(4):526-31. PubMed ID: 23524257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling.
    Liu L; Hu X; Cai GY; Lv Y; Zhuo L; Gao JJ; Cui SY; Feng Z; Fu B; Chen XM
    Nephrol Dial Transplant; 2012 Jan; 27(1):90-100. PubMed ID: 21633095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated DJ-1 promotes renal tubular EMT by suppressing cytoplasmic PTEN expression and Akt activation.
    Yao Y; Wei H; Liu L; Liu L; Bai S; Li C; Luo Y; Zeng R; Han M; Ge S; Xu G
    J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):469. PubMed ID: 21823007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src Homology 2 Domain-Containing Inositol 5'-Phosphatase Ameliorates High Glucose-Induced Extracellular Matrix Deposition via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Renal Tubular Epithelial Cells.
    Li F; Li L; Hao J; Liu S; Duan H
    J Cell Biochem; 2017 Aug; 118(8):2271-2284. PubMed ID: 28075049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-fat diet causes increased serum insulin and glucose which synergistically lead to renal tubular lipid deposition and extracellular matrix accumulation.
    Hao J; Liu SX; Zhao S; Liu QJ; Liu W; Duan HJ
    Br J Nutr; 2012 Jan; 107(1):74-85. PubMed ID: 21733321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
    Huang LH; Chung HY; Su HM
    BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion.
    Bera A; Das F; Ghosh-Choudhury N; Mariappan MM; Kasinath BS; Ghosh Choudhury G
    Am J Physiol Cell Physiol; 2017 Oct; 313(4):C430-C447. PubMed ID: 28701356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SREBP-1 activation by glucose mediates TGF-β upregulation in mesangial cells.
    Uttarwar L; Gao B; Ingram AJ; Krepinsky JC
    Am J Physiol Renal Physiol; 2012 Feb; 302(3):F329-41. PubMed ID: 22031849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
    McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
    Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.